Cellular Immunotherapy Market (2022 - 2030) Size, Share & Trends Analysis Report By Therapy Type (CAR T Cell Therapy, Dendritic Cell Therapy), By Indication (B-cell Malignancies, Prostate Cancer), By End-use, By Region, And Segment Forecasts

Market Segmentation

• Cellular Immunotherapy Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)
  
  • CAR T Cell Therapy
  • Dendritic Cell Therapy
  • NK Cell Therapy
  • TIL Therapy
  • Others
• Cellular Immunotherapy Indication Outlook (Revenue, USD Million, 2018 - 2030)
  
  • B-cell Malignancies
  • Prostate Cancer
  • Liver Cancer
  • Renal Cell Carcinoma
  • Others
• Cellular Immunotherapy End Use Outlook (Revenue, USD Million, 2018 - 2030)
  
  • Hospitals
  • Cancer Institutes
  • Others
• Cellular Immunotherapy Regional Outlook (Revenue, USD Million, 2018 - 2030)
  
  • North America
    
    • North America Cellular Immunotherapy Market, By Therapy Type
      
      • CAR T Cell Therapy
      • Dendritic Cell Therapy
      • NK Cell Therapy
      • TIL Therapy
      • Others
    • North America Cellular Immunotherapy Market, By Indication
      
      • B-cell Malignancies
      • Prostate Cancer
      • Liver Cancer
      • Renal Cell Carcinoma
      • Others
    • North America Cellular Immunotherapy Market, By End Use
      
      • Hospitals
      • Cancer Institutes
      • Others
    • U.S.
      
      • U.S. Cellular Immunotherapy Market, By Therapy Type
        
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • U.S. Cellular Immunotherapy Market, By Indication
        
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • U.S. Cellular Immunotherapy Market, By End Use
        
        • Hospitals
        • Cancer Institutes
        • Others
    • Canada
      
      • Canada Cellular Immunotherapy Market, By Therapy Type
        
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Canada Cellular Immunotherapy Market, By Indication
        
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Canada Cellular Immunotherapy Market, By End Use
        
        • Hospitals
        • Cancer Institutes
        • Others
  • Europe
    
    • Europe Cellular Immunotherapy Market, By Therapy Type
      
      • CAR T Cell Therapy
      • Dendritic Cell Therapy
      • NK Cell Therapy
      • TIL Therapy
      • Others
    • Europe Cellular Immunotherapy Market, By Indication
      
      • B-cell Malignancies
      • Prostate Cancer
      • Liver Cancer
      • Renal Cell Carcinoma
      • Others
    • Europe Cellular Immunotherapy Market, By End Use
      
      • Hospitals
      • Cancer Institutes
      • Others
    • U.K.
      
      • U.K. Cellular Immunotherapy Market, By Therapy Type
        
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • U.K. Cellular Immunotherapy Market, By Indication
        
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • U.K. Cellular Immunotherapy Market, By End Use
        
        • Hospitals
        • Cancer Institutes
        • Others
    • Germany
      
      • Germany Cellular Immunotherapy Market, By Therapy Type
        
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Germany Cellular Immunotherapy Market, By Indication
        
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Germany Cellular Immunotherapy Market, By End Use
        
        • Hospitals
        • Cancer Institutes
        • Others
    • France
      
      • France Cellular Immunotherapy Market, By Therapy Type
        
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • France Cellular Immunotherapy Market, By Indication
        
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • France Cellular Immunotherapy Market, By End Use
        
        • Hospitals
        • Cancer Institutes
        • Others
    • Italy
      
      • Italy Cellular Immunotherapy Market, By Therapy Type
        
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Italy Cellular Immunotherapy Market, By Indication
        
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Italy Cellular Immunotherapy Market, By End Use
        
        • Hospitals
        • Cancer Institutes
        • Others
    • Spain
      
      • Spain Cellular Immunotherapy Market, By Therapy Type
        
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Spain Cellular Immunotherapy Market, By Indication
        
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Spain Cellular Immunotherapy Market, By End Use
        
        • Hospitals
        • Cancer Institutes
        • Others
    • Russia
      
      • Russia Cellular Immunotherapy Market, By Therapy Type
        
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Russia Cellular Immunotherapy Market, By Indication
        
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Russia Cellular Immunotherapy Market, By End Use
        
        • Hospitals
        • Cancer Institutes
        • Others
  • Asia Pacific
    
    • Asia Pacific Cellular Immunotherapy Market, By Therapy Type
      
      • CAR T Cell Therapy
      • Dendritic Cell Therapy
      • NK Cell Therapy
      • TIL Therapy
      • Others
    • Asia Pacific Cellular Immunotherapy Market, By Indication
      • B-cell Malignancies
      • Prostate Cancer
      • Liver Cancer
      • Renal Cell Carcinoma
      • Others
    • Asia Pacific Cellular Immunotherapy Market, By End Use
      • Hospitals
      • Cancer Institutes
      • Others
    • Japan
      • Japan Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Japan Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Japan Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
    • China
      • China Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • China Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • China Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
    • India
      • India Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • India Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • India Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
    • Australia
      • Australia Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Australia Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Australia Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
    • South Korea
      • South Korea Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • South Korea Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • South Korea Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
  • Latin America
    
    • Latin America Cellular Immunotherapy Market, By Therapy Type
      • CAR T Cell Therapy
      • Dendritic Cell Therapy
      • NK Cell Therapy
      • TIL Therapy
      • Others
    • Latin America Cellular Immunotherapy Market, By Indication
      • B-cell Malignancies
      • Prostate Cancer
      • Liver Cancer
      • Renal Cell Carcinoma
      • Others
    • Latin America Cellular Immunotherapy Market, By End Use
      • Hospitals
      • Cancer Institutes
      • Others
    • Brazil
      • Brazil Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Brazil Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Brazil Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
    • Mexico
      • Mexico Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Mexico Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Mexico Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
    • Argentina
      • Argentina Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Argentina Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Argentina Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
  • MEA
    
    • MEA Cellular Immunotherapy Market, By Therapy Type
      • CAR T Cell Therapy
      • Dendritic Cell Therapy
      • NK Cell Therapy
      • TIL Therapy
      • Others
    • MEA Cellular Immunotherapy Market, By Indication
      • B-cell Malignancies
      • Prostate Cancer
      • Liver Cancer
      • Renal Cell Carcinoma
      • Others
    • MEA Cellular Immunotherapy Market, By End Use
      • Hospitals
      • Cancer Institutes
      • Others
    • South Africa
      • South Africa Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • South Africa Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • South Africa Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
    • Saudi Arabia
      • Saudi Arabia Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • Saudi Arabia Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • Saudi Arabia Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others
    • UAE
      • UAE Cellular Immunotherapy Market, By Therapy Type
        • CAR T Cell Therapy
        • Dendritic Cell Therapy
        • NK Cell Therapy
        • TIL Therapy
        • Others
      • UAE Cellular Immunotherapy Market, By Indication
        • B-cell Malignancies
        • Prostate Cancer
        • Liver Cancer
        • Renal Cell Carcinoma
        • Others
      • UAE Cellular Immunotherapy Market, By End Use
        • Hospitals
        • Cancer Institutes
        • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance